Search Results - "Delsing, Bas J.P."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Early prognostic indicators of outcome in ischemic childhood stroke by Delsing, Bas J.P, Catsman-Berrevoets, Coriene E, Appel, Inge M

    Published in Pediatric neurology (01-04-2001)
    “…The aim of this study was to identify early prognostic factors in children with ischemic arterial stroke. Presenting symptoms, patterns of infarction on…”
    Get full text
    Journal Article
  2. 2

    Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial by Mazur, Natalie I., Löwensteyn, Yvette N., Terstappen, Jonne, Leusen, Jeanette, Schobben, Fred, Cianci, Daniela, van de Ven, Peter M., Nierkens, Stefan, Bont, Louis J., Nibbelke, Elisabeth E., Buiteman, Brigitte, Rave, Neele, Putten, Marlies Vermaas-van, Smit-Kleinlugtenbeld, Elly A., de Lege-Korstanje, Jacqueline P., Peetsold, Marieke G., Hulsmann, Anthon, van Gool, Sandy, Snepvangers, Yvonne, Colombijn, Max, Menelik, Negassi, de Crom, Stephanie, Semmekrot, Ben, de Waal, Wouter J., Okhuijsen, Eline, ten Tusscher, Gavin W., de Moor, Ronald A., Breukels, Mijke A., Lutterman, Claire, Tramper-Stranders, Gerdien A., Oudshoorn, Johanna H., Ritman, Astrid, von Lindern, Jeannette S., Dubbink-Verheij, Gerdina H., van den Berg, Maartje M., Wilsterman, Marlon E.F., Rietveld, Edwin, van Heel, Willemijn, de Grauw, Anne M., Croes, Femke, Doedens, Rienus A., van Onzenoort-Bokken, Lonneke, Meijssen, Clemens B., van Scherpenzeel-de Vries, Machteld, Hoekstra, Petra, van Rooij, Linda G.M., Boode, Willem-Pieter de, van Rossem, Maaike C., Sipkema, Petra, Jacobs, Monique A.M., van Houten, Marianne A., Kok-Wijesinha, Indrani, Vlieger, Arine M., Balemans, Walter, Plötz, Frans B., Reijmerink, Naomi, van Dorth, Stefan M., Heikens, Willem, Kuijpers, Anke G., Geesing, Christel, Delsing, Bas J.P., Aldenhoven, Mieke, Illy, Karoly, Hack, Eric, Groenendaal, Floris, Derksen, Nicole, Rengerink, Katrien Oude, Meeldijk, Jan, Ebskamp-van Raaij, Lysette, de Groot-Mijnes, Jolanda D.F., Schuurman, Rob

    Published in EClinicalMedicine (01-12-2023)
    “…Mucosal administration of monoclonal antibodies (mAbs) against respiratory pathogens is a promising alternative for systemic administration because lower doses…”
    Get full text
    Journal Article
  3. 3

    Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trialResearch in context by Natalie I. Mazur, Yvette N. Löwensteyn, Jonne Terstappen, Jeanette Leusen, Fred Schobben, Daniela Cianci, Peter M. van de Ven, Stefan Nierkens, Louis J. Bont, Elisabeth E. Nibbelke, Brigitte Buiteman, Neele Rave, Marlies Vermaas-van Putten, Elly A. Smit-Kleinlugtenbeld, Jacqueline P. de Lege-Korstanje, Marieke G. Peetsold, Anthon Hulsmann, Sandy van Gool, Yvonne Snepvangers, Max Colombijn, Negassi Menelik, Stephanie de Crom, Ben Semmekrot, Wouter J. de Waal, Eline Okhuijsen, Gavin W. ten Tusscher, Ronald A. de Moor, Mijke A. Breukels, Claire Lutterman, Gerdien A. Tramper-Stranders, Johanna H. Oudshoorn, Astrid Ritman, Jeannette S. von Lindern, Gerdina H. Dubbink-Verheij, Maartje M. van den Berg, Marlon E.F. Wilsterman, Edwin Rietveld, Willemijn van Heel, Anne M. de Grauw, Femke Croes, Rienus A. Doedens, Lonneke van Onzenoort-Bokken, Clemens B. Meijssen, Machteld van Scherpenzeel-de Vries, Petra Hoekstra, Linda G.M. van Rooij, Willem-Pieter de Boode, Maaike C. van Rossem, Petra Sipkema, Monique A.M. Jacobs, Marianne A. van Houten, Indrani Kok-Wijesinha, Arine M. Vlieger, Walter Balemans, Frans B. Plötz, Naomi Reijmerink, Stefan M. van Dorth, Willem Heikens, Anke G. Kuijpers, Christel Geesing, Bas J.P. Delsing, Mieke Aldenhoven, Karoly Illy, Eric Hack, Floris Groenendaal, Nicole Derksen, Katrien Oude Rengerink, Jan Meeldijk, Lysette Ebskamp-van Raaij, Jolanda D.F. de Groot-Mijnes, Rob Schuurman

    Published in EClinicalMedicine (01-12-2023)
    “…Background: Mucosal administration of monoclonal antibodies (mAbs) against respiratory pathogens is a promising alternative for systemic administration because…”
    Get full text
    Journal Article
  4. 4